Fairvalue-Calculator Fairvalue-Calculator
EN DE

BARRA (BARRA) Fair Value & Analysis

Consumer Defensive · Market cap 125M NOK

B BARRA BARRA · OL
Pricekr 0.7150
Fair Valuekr 0.9200
Upside+28.7%
Quality80/100
Evidence: Medium Range kr 0.6900 – kr 3.68

Fair value as of: Jun 30, 2026

From 10 valuation models · updated today

Share price +2.1% over the past month.

Price vs Fair Value (12 months)

kr 1.70 kr 0.3788 Fair Value kr 0.9200 Jun 2025 Jun 2026

12‑month range kr 0.3788 – kr 1.70 · fair‑value band kr 0.6900 – kr 3.68 · the kr 0.7150 price screens below the kr 0.9200 fair value. As of Jun 30, 2026.

✦ Find undervalued quality stocks — 35,000+ analysed Find stocks →

Analysis

BARRA (BARRA) currently trades at kr 0.7150, while our model-based Fair Value estimate is kr 0.9200 — implying the stock looks roughly 28.7% undervalued today. We read business quality at 80/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

Over the trailing twelve months, BARRA generated revenue of 13.8M NOK at a net margin of -60.2%. Revenue declined 1.7% year over year. Net debt stands at 13.0M NOK. The stock trades on a trailing P/E of 6.5. Fundamentals as of Jun 30, 2026

Key figures & financial health

Revenue (TTM) 13.1M NOK
Revenue growth (YoY) -10.3%
Net margin 18.4%
Return on equity 54.4%
Free cash flow −5.0M NOK FY2025
P/E ratio 6.5
More key figures
Operating margin -67.1%
EPS (TTM) kr 0.1100
Net debt 13.0M NOK FY2025

Figures from reported company fundamentals (EODHD) · as of Jun 30, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

BARRA reported revenue of kr 13.1M in FY2025 versus kr 32.7M in FY2021, a compound −20.4%/yr. Reported net income was kr 2.4M in FY2025.

Revenue −20.4%/yr
FY21 kr 32.7M
FY22 kr 19.7M
FY23 kr 16.6M
FY24 kr 112M
FY25 kr 13.1M
Net income
FY21 −kr 25.5M
FY22 −kr 30.7M
FY23 −kr 12.6M
FY24 −kr 66.9M
FY25 kr 2.4M

Open the full interactive analysis →

Similar stocks

6 more Farm Products stocks, each showing price versus our Fair Value estimate (as of Jun 30, 2026).

Stock Price Fair Value vs Fair Value
Archer-Daniels-Midland Company ADM $83.37 $35.54 -57%
MHP SE MHPC $0.0854 $0.0100 -88%
Muyuan Foods Group 002714 ¥33.95 ¥119.07 +251%
Bunge Global SA BG $129.13 $136.85 +6%
Tyson Foods, Inc TSN $55.51 $46.40 -16%
Wens Foodstuff Group 300498 ¥12.89 ¥6.35 -51%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is BARRA (BARRA) undervalued?
As of Jun 30, 2026, our model estimates a fair value of kr 0.9200 versus a price of kr 0.7150 — about +29% (undervalued). Model-based estimate, not financial advice.
What is the fair value of BARRA?
Our 21-model fair value for BARRA is kr 0.9200 (as of Jun 30, 2026), built from audited fundamentals. The current price is kr 0.7150.
What is the quality score of BARRA?
BARRA has a Quality Score of 80/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of BARRA (BARRA)?
BARRA reported trailing-twelve-month revenue of about 13.8M NOK (latest available figure, as of Jun 30, 2026).
What is the net profit margin of BARRA?
The net profit margin of BARRA is about -60.2%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.